Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia
© 2020 International Society on Thrombosis and Haemostasis..
BACKGROUND: Thrombin generation assays (TGAs) performed with calibrated automated thrombography (CAT) in the presence of thrombomodulin (TM) indicate plasma hypercoagulability in cirrhosis.
OBJECTIVE: To evaluate, in the presence of TM, the new ST-Genesia automated device developed for improving TGA vs the previously used CAT method, with plasma samples of patients with cirrhosis.
PATIENTS/METHODS: Platelet-poor plasma samples were prepared from citrated blood samples of 52 healthy controls and 85 patients with cirrhosis (severity evaluated using the Child-Pugh score [CP]). TGAs were performed using CAT with PPP-Reagent and ST-Genesia with the STG-ThromboScreen reagent, in the presence of TM. Endogenous thrombin potential (ETP) was chosen as the main parameter.
RESULTS: Whatever the method, ETP values were higher in patients than in healthy controls. All patients identified as hypercoagulable with ST-Genesia and STG-ThromboScreen were found hypercoagulable with CAT and PPP-Reagent. Conversely, eight and ten patients in the CP-A and CP-B classes respectively were identified as hypercoagulable only with CAT. The use of ST-Genesia with the STG-ThromboScreen reagent with TM led to a bias, with higher ETP values for healthy controls and lower for patients compared with CAT. Crossover analysis (CAT with the STG-ThromboScreen reagent) evidenced a substantial effect of the STG-ThromboScreen reagent; the analyzer (including calibration and data analysis) plays a lesser role.
CONCLUSION: ST-Genesia evidences hypercoagulability in patients with cirrhosis when TG is studied in the presence of TM, but the results are not interchangeable with those obtained with CAT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Journal of thrombosis and haemostasis : JTH - 18(2020), 9 vom: 19. Sept., Seite 2177-2190 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Talon, Laurie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Blood coagulation |
---|
Anmerkungen: |
Date Completed 19.05.2021 Date Revised 29.08.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jth.14963 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311370322 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311370322 | ||
003 | DE-627 | ||
005 | 20231225142115.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jth.14963 |2 doi | |
028 | 5 | 2 | |a pubmed24n1037.xml |
035 | |a (DE-627)NLM311370322 | ||
035 | |a (NLM)32558351 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Talon, Laurie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.05.2021 | ||
500 | |a Date Revised 29.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 International Society on Thrombosis and Haemostasis. | ||
520 | |a BACKGROUND: Thrombin generation assays (TGAs) performed with calibrated automated thrombography (CAT) in the presence of thrombomodulin (TM) indicate plasma hypercoagulability in cirrhosis | ||
520 | |a OBJECTIVE: To evaluate, in the presence of TM, the new ST-Genesia automated device developed for improving TGA vs the previously used CAT method, with plasma samples of patients with cirrhosis | ||
520 | |a PATIENTS/METHODS: Platelet-poor plasma samples were prepared from citrated blood samples of 52 healthy controls and 85 patients with cirrhosis (severity evaluated using the Child-Pugh score [CP]). TGAs were performed using CAT with PPP-Reagent and ST-Genesia with the STG-ThromboScreen reagent, in the presence of TM. Endogenous thrombin potential (ETP) was chosen as the main parameter | ||
520 | |a RESULTS: Whatever the method, ETP values were higher in patients than in healthy controls. All patients identified as hypercoagulable with ST-Genesia and STG-ThromboScreen were found hypercoagulable with CAT and PPP-Reagent. Conversely, eight and ten patients in the CP-A and CP-B classes respectively were identified as hypercoagulable only with CAT. The use of ST-Genesia with the STG-ThromboScreen reagent with TM led to a bias, with higher ETP values for healthy controls and lower for patients compared with CAT. Crossover analysis (CAT with the STG-ThromboScreen reagent) evidenced a substantial effect of the STG-ThromboScreen reagent; the analyzer (including calibration and data analysis) plays a lesser role | ||
520 | |a CONCLUSION: ST-Genesia evidences hypercoagulability in patients with cirrhosis when TG is studied in the presence of TM, but the results are not interchangeable with those obtained with CAT | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a blood coagulation | |
650 | 4 | |a blood coagulation test | |
650 | 4 | |a clinical laboratory techniques | |
650 | 4 | |a liver cirrhosis | |
650 | 4 | |a thrombomodulin | |
650 | 7 | |a Thrombin |2 NLM | |
650 | 7 | |a EC 3.4.21.5 |2 NLM | |
700 | 1 | |a Sinegre, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Lecompte, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Pereira, Bruno |e verfasserin |4 aut | |
700 | 1 | |a Massoulié, Sylvie |e verfasserin |4 aut | |
700 | 1 | |a Abergel, Armand |e verfasserin |4 aut | |
700 | 1 | |a Lebreton, Aurélien |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of thrombosis and haemostasis : JTH |d 2003 |g 18(2020), 9 vom: 19. Sept., Seite 2177-2190 |w (DE-627)NLM126285683 |x 1538-7836 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2020 |g number:9 |g day:19 |g month:09 |g pages:2177-2190 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jth.14963 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2020 |e 9 |b 19 |c 09 |h 2177-2190 |